A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)
Phase 2
Not yet recruiting
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Biological: STR04
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- New England Cell Therapeutics, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT06910384
© Copyright 2025. All Rights Reserved by MedPath